Journal
INFLUENZA AND OTHER RESPIRATORY VIRUSES
Volume 1, Issue 3, Pages 105-112Publisher
WILEY
DOI: 10.1111/j.1750-2659.2007.00016.x
Keywords
H5N1; influenza; pseudotypes; serology; viral neutralization
Categories
Funding
- Medical Research Council
- Wellcome Trust
- Health Protection Agency
- MRC [G0600369, G8712499] Funding Source: UKRI
- Medical Research Council [G0600369, G8712499] Funding Source: researchfish
Ask authors/readers for more resources
Background The World Health Organisation (WHO) recommended the development of simple, safe, sensitive and specific neutralization assays for avian influenza antibodies. We have used retroviral pseudotypes bearing influenza H5 hemagglutinin (HA) as safe, surrogate viruses for influenza neutralization assays which can be carried out at Biosafety Level 2. Results Using our assay, sera from patients who had recovered from infection with influenza H5N1, and sera from animals experimentally immunized or infected with H5 tested positive for the presence of neutralizing antibodies to H5N1. Pseudotype neutralizing antibody titers were compared with titers obtained by hemagglutinin inhibition (HI) assays and microneutralization (MN) assays using live virus, and showed a high degree of correlation, sensitivity and specificity. Conclusions The pseudotype neutralization assay is as sensitive as horse erythrocyte HI and MN for the detection of antibodies to H5N1. It is safer, and can be applied in a high-throughput format for human and animal surveillance and for the evaluation of vaccines.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available